EUVIMEDEUVIMED entdecken
Crossref

Topical Application of Fluoxetine Improves DNCB ‐Induced Atopic Dermatitis in Mice

Xue Jiang, Xiaobin Wu iD, Fujin Yang, Yanxi Li

Experimental Dermatology · 2025

DOI: 10.1111/exd.70096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Xue Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chongqing Tranditional Chinese Medicine Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Fluoxetine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: the "Xinglin Scholars" Disciplinary talents research promotion plan (No. YYZX2020047), Natural Science Foundation of Chongqing (No. jxyn2020-7), the Senior Medical Talents Program of Chongqing for Yong and Middle-aged, the Program for Scientific Institutions of Chongqing (No. 2022GDRC015).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to assess the therapeutic effects and underlying mechanisms of topical fluoxetine application in an atopic dermatitis (AD)‐like mouse model. An AD‐like mouse model was established using 2,4‐dinitrochlorobenzene (DNCB) and treated with topical applications of fluoxetine on skin lesions. The therapeutic efficacy was evaluated by measuring the number of scratches, skin thickness, trans‐epidermal water loss (TEWL), and skin moisture levels. Histopathological changes were examined through haematoxylin and eosin staining and toluidine blue staining to assess the local inflammatory state. Quantitative PCR (qPCR) was used to measure the expression of Th2‐related cytokines (IL‐5, IL‐13, and IL‐31) in skin lesions. Serum levels of IgE and thymus‐ and activation‐regulated chemokine (TARC) were measured by enzyme‐linked immunosorbent assay (ELISA). Topical fluoxetine significantly alleviated lesion symptoms in AD‐like mice, reducing skin thickness and the number of scratching incidents. The treatment enhanced skin barrier recovery and reduced the infiltration of inflammatory cells, especially mast cells. Levels of Th2‐related cytokines (IL‐5, IL‐13, and IL‐31), indicative of local immune status, were also decreased. Serum concentrations of IgE and TARC showed a downward trend, with a more pronounced decrease in TARC levels. Our findings support the therapeutic role of topical fluoxetine in an AD‐like mouse model through the repair of the skin barrier and inhibition of the Th2 inflammatory response in skin lesions, while also alleviating pruritus. These results suggest that fluoxetine may be a potential therapeutic candidate for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicFluoxetineAnimalsDinitrochlorobenzeneMiceImmunoglobulin EDisease Models, AnimalCytokinesMice, Inbred BALB CAdministration, TopicalSkinInterleukinsInterleukin-13FemaleTh2 CellsMast CellsInterleukin-5

Stichwörter der Autor:innen

atopic dermatitisfluoxetineinflammationmicepruritusskin barrier

Substanzen

FluoxetineDinitrochlorobenzeneImmunoglobulin ECytokinesinterleukin-31, mouseInterleukinsInterleukin-13Interleukin-5

Autor:innen und Institutionen

  • Department of Dermatology, Chongqing Tranditional Chinese Medicine Hospital, Chongqing, China.
  • Department of Paediatrics, Chongqing Health Center for Women and Children, Chongqing, China.
  • Chongqing Medical University, Women and Children's Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Xiaobin Wu

Förderung

  • the "Xinglin Scholars" Disciplinary talents research promotion plan (No. YYZX2020047)
  • Natural Science Foundation of Chongqing (No. jxyn2020-7)
  • the Senior Medical Talents Program of Chongqing for Yong and Middle-aged, the Program for Scientific Institutions of Chongqing (No. 2022GDRC015)
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Jiang, X., Wu, X., Yang, F., & Li, Y. (2025). Topical Application of Fluoxetine Improves DNCB ‐Induced Atopic Dermatitis in Mice. Experimental Dermatology. https://doi.org/10.1111/exd.70096

Vancouver

Jiang X, Wu X, Yang F, Li Y. Topical Application of Fluoxetine Improves DNCB ‐Induced Atopic Dermatitis in Mice. Experimental Dermatology. 2025. doi:10.1111/exd.70096

BibTeX
@article{Jiang2025,
  author = {Jiang, Xue and Wu, Xiaobin and Yang, Fujin and Li, Yanxi},
  title = {Topical Application of Fluoxetine Improves DNCB ‐Induced Atopic Dermatitis in Mice},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70096}
}
Kostenlos starten →